2026年第一季度报告（英文版）

First Quarterly Report 2026 of Huadong Medicine Co., Ltd.1Stock code: 000963Stock abbreviation: Huadong MedicineAnnouncement No.: 2026-030Huadong Medicine Co., Ltd.First Quarterly Report 2026The Company and all members of the Board of Directors hereby guarantee that the information presented in this report isauthentic, accurate and complete and free of any false records, misleading statements or material omissions.Important Declaration:1. The Board of Directors, directors and senior management of Huadong Medicine Co., Ltd. (hereinafter referred to as the"Company") hereby guarantee that the information presented in the Report is authentic, accurate and complete and free of falserecords, misleading statements or material omissions, and shall undertake individual and joint legal liabilities.2. The Company's legal representative, the officer in charge of accounting, and the head of Accounting Department (accountingmanager) hereby declare that the financial information in this quarterly report is authentic, accurate and complete.3. Has the First Quarterly Report been audited?□Yes NoAccording to “Stock Listing Rules of the Shenzhen Stock Exchange”, if listed companies have both Chinese and other languageversion of public notice, they should ensure the content of both versions are the same. In the case of discrepancy, the originalversion in Chinese shall prevail.First Quarterly Report 2026 of Huadong Medicine Co., Ltd.2I. Key Financial Data(I) Key accounting data and financial indicatorsWhether the Company needs to perform a retroactive adjustment or restatement of previous accounting data□Yes NoCurrent reporting periodSame period last yearYear-on-year change for thereporting period (%)Operating revenue (RMB)11,183,450,824.2710,735,787,899.824.17%Net profits attributable toshareholders of the listedcompany (RMB)1,002,189,357.16914,708,484.709.56%Net profits attributable toshareholders of the listedcompany after deduction ofnon-recurring profit and loss(RMB)989,719,668.99897,337,982.4210.30%Net cash flow from operatingactivities (RMB)-852,335,762.63-832,728,693.88-2.35%Basic earnings per share(RMB/share)0.57150.52249.40%Diluted earnings per share(RMB/share)0.57150.52139.63%Weighted average return onequity3.97%3.88%0.09%End of the current reportingperiodEnd of the last yearChange from prior year-end(%)Total assets (RMB)39,908,042,564.9439,038,036,320.922.23%Owners' equity attributable toshareholders of listedcompanies (RMB)25,733,074,032.1024,811,339,992.993.71%The Company's total share capital as of the trading day prior to disclosure:The Company’s total share capital as of the trading day prior todisclosure (shares)1,753,736,848.00Fully diluted earnings per share based on the latest share capital:Preferred dividends paid (RMB)0.00Paid perpetual bond interest (RMB)0.00Fully diluted earnings per share based on the latest share capital(RMB/share)0.5715(II) Non-recurring profit and loss items and amountsApplicable □Not applicableUnit: RMBItemAmount durin